Revenue
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Gevo, Inc. (GEVO)
Price$1.64Cached quote
Net income
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $160.6M | $16.9M | $17.2M | $1.2M | $533,000 | $5.5M | $24.5M | $32.9M | $27.3M | $26.5M | $30.1M | $28.3M | $8.2M | $24.4M | $64.5M | $16.4M | $660,000 | — | — | — |
| Gross profit | $75.3M | $4.9M | $5.2M | −$7.5M | −$11.5M | −$9.5M | −$12.2M | −$8.7M | −$10.6M | −$9.8M | −$8.6M | −$7.3M | −$9.7M | −$8.0M | $4.0M | $3.0M | $660,000 | — | — | — |
| Gross margin | 46.92% | 29.05% | 30.28% | −640.26% | −2,148.97% | −173.29% | −50.08% | −26.49% | −38.92% | −36.94% | −28.62% | −25.88% | −117.81% | −32.91% | 6.14% | 17.99% | 100.00% | — | — | — |
| Research & development | $4.5M | $5.6M | $6.6M | $7.4M | $6.8M | $3.5M | $3.9M | $5.4M | $5.2M | $5.2M | $6.6M | $14.1M | $20.2M | $19.4M | $19.8M | $14.8M | $10.5M | — | — | — |
| Operating expenses | $180.8M | $107.7M | $99.0M | $103.9M | $60.8M | $17.5M | $14.1M | $13.5M | $12.7M | $14.2M | $23.3M | $32.5M | $45.8M | $63.4M | $48.7M | $38.5M | $19.2M | — | — | — |
| Operating income | −$20.2M | −$90.8M | −$81.8M | −$102.7M | −$60.3M | −$27.0M | −$26.4M | −$22.2M | −$23.3M | −$24.0M | −$31.9M | −$39.8M | −$55.5M | −$71.4M | −$44.7M | −$35.5M | — | — | — | — |
| Operating margin | −12.59% | −536.94% | −475.78% | −8,739.23% | −11,307.32% | −493.52% | −107.78% | −67.56% | −85.26% | −90.37% | −105.94% | −140.72% | −675.04% | −292.95% | −69.24% | −216.60% | — | — | — | — |
| EBITDA | $5.1M | −$72.5M | −$62.8M | −$94.8M | −$55.1M | −$21.1M | −$19.7M | −$15.7M | −$16.6M | −$17.2M | −$25.4M | −$34.9M | −$52.1M | −$68.1M | −$40.1M | −$32.3M | — | — | — | — |
| EBITDA margin | 3.18% | −428.77% | −365.28% | −8,068.00% | −10,345.22% | −385.45% | −80.56% | −47.73% | −60.94% | −64.95% | −84.13% | −123.46% | −633.78% | −279.37% | −62.11% | −197.15% | — | — | — | — |
| Net income | −$33.8M | −$78.6M | −$66.2M | −$98.0M | −$59.2M | −$40.2M | −$28.7M | −$28.0M | −$24.6M | −$37.2M | −$36.2M | −$41.1M | −$66.8M | −$60.7M | −$48.2M | −$40.1M | −$19.9M | −$14.5M | −$7.2M | −$1.1M |
| Net profit margin | −21.07% | −464.91% | −384.97% | −8,341.02% | −11,107.50% | −735.60% | −117.20% | −85.13% | −90.19% | −140.26% | −120.10% | −145.56% | −812.33% | −248.97% | −74.69% | −244.65% | −3,012.88% | — | — | — |
| Basic EPSper basic share | -$0.14 | -$0.34 | -$0.28 | -$0.44 | -$0.30 | -$0.71 | -$2.35 | -$5.74 | -$30.23 | -$193.52 | -$1,032.20 | -$3,067.00 | -$177,840.00 | -$3,331,343.28 | -$3,850,746.27 | -$67,056,716.42 | -$32,364,179.10 | — | — | — |
| Diluted EPSper diluted share | -$0.14 | -$0.34 | -$0.28 | -$0.44 | -$0.30 | -$0.71 | -$2.35 | -$5.74 | -$30.23 | -$193.52 | -$1,032.20 | -$3,067.00 | -$177,840.00 | -$3,331,343.28 | -$3,850,746.27 | -$67,056,716.42 | -$32,364,179.10 | — | — | — |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Gruber Patrick R. | 3.6M |
Bloom Paul D | 1.51M |
Ryan Christopher Michael | 1.31M |
Smull L Lynn | 1.12M |
Bowron Kimberly T | 711.27K |
Agiri Oluwagbemileke Yusuf | 515.98K |
Mize Gary W. | 351.23K |
Marsh Andrew | 343.67K |
Shafer Andrew | 328.47K |
Fitzgerald Lindsay Clinton | 292.26K |
Battershell Carol Jane | 278.27K |
JAMES KYLE DEAN | 266.45K |
Kettner David Michael | 264.29K |
Guillen Jaime | 264.05K |
Nurmat Alisher K | 207.78K |
Ellet Mary Kathryn | 132.82K |
Gendenjamts Davaajargal | 115.66K |
Barber James J | 70K |
Amorelli Angelo | — |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 12, 2026Form 4 · 10b5-1 | Agiri Oluwagbemileke YusufCFO | SellCommon Stock | 63.0K | $1.40 | $88.2K | 491.1K |
| Jun 12, 2026Form 4 · 10b5-1 | Gendenjamts DavaajargalVP Acctg and Treasurer | SellCommon Stock | 4.3K | $1.43 | $6.1K | 108.9K |
| Jun 12, 2026Form 4 · 10b5-1 | Shafer AndrewChief Mktg Cust & Brnd Officer | SellCommon Stock | 9.4K | $1.43 | $13.5K | 311.6K |
| Jun 12, 2026Form 4 · 10b5-1 | Bowron Kimberly TChief of Staff | SellCommon Stock | 15.5K | $1.43 | $22.1K | 696.3K |
| Jun 12, 2026Form 4 · 10b5-1 | Bloom Paul DCEO | SellCommon Stock | 35.2K | $1.43 | $50.3K | 1.48M |
Community posts
Gevo and Praj sign exclusive Indian bio-isobutanol commercialization deal
Gevo ($GEVO) and Praj Industries signed a development and commercialization agreement for renewable isobutanol in India. Praj will lead local commercialization and hold exclusive deployment rights in the country. The initial emphasis is on ...
